BCM
EVH icon

Bridgeway Capital Management’s Evolent Health EVH Stock Holding History

Bridgeway Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$813K Buy
+150,000
New +$575K 0.01% 774

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bridgeway Capital Management's EVH Position: Q2 2026 in Review

Bridgeway Capital Management opened a new position in Evolent Health (EVH) in Q2 2026: 150,000 shares worth $813K. The stake represents 0.01% of the portfolio and ranks #774 among its holdings.

199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Bridgeway Capital Management held 150,000 shares of Evolent Health worth $813K as of Q2 2026.
  • Evolent Health was a new Bridgeway Capital Management position in Q2 2026.
  • Evolent Health made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #774 holding.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.